AU Stock MarketDetailed Quotes

RAD Radiopharm Theranostics Ltd

Watchlist
  • 0.025
  • -0.001-3.85%
20min DelayMarket Closed Nov 22 16:00 AET
54.32MMarket Cap-201P/E (Static)

Radiopharm Theranostics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities
176.71%5.11M
118.63%1.85M
-9.92M
Revenue from customers
-10.91%260.46K
102.95%292.36K
---9.92M
Other cash income from operating activities
211.98%4.85M
--1.56M
----
Cash paid
-11.69%-28.14M
-25.19M
Payments to suppliers for goods and services
-11.69%-28.14M
---25.19M
----
Direct interest received
-65.19%50.48K
--145.04K
----
Operating cash flow
0.97%-22.98M
-133.99%-23.2M
---9.92M
Investing cash flow
Cash flow from continuing investing activities
94.60%-1.53M
-28.37M
Net PPE purchase and sale
----
-1,548.09%-45.31K
---2.75K
Net intangibles purchas and sale
----
94.76%-1.49M
---28.34M
Interest received (cash flow from investment activities)
----
----
--8.83K
Net other investing changes
----
----
---40K
Cash from discontinued investing activities
Investing cash flow
----
94.60%-1.53M
---28.37M
Financing cash flow
Cash flow from continuing financing activities
224.12%29.88M
-85.84%9.22M
65.11M
Net issuance payments of debt
--2.2M
----
---59K
Net common stock issuance
204.97%28.11M
-85.86%9.22M
--65.17M
Net other financing activities
---437K
----
----
Cash from discontinued financing activities
Financing cash flow
224.12%29.88M
-85.84%9.22M
--65.11M
Net cash flow
Beginning cash position
-56.64%11.7M
99,486.97%26.98M
--27.09K
Current changes in cash
144.48%6.9M
-157.84%-15.51M
--26.82M
Effect of exchange rate changes
-110.67%-25.04K
84.22%234.65K
--127.37K
End cash Position
58.77%18.58M
-56.64%11.7M
--26.98M
Free cash from
7.10%-22.98M
35.35%-24.73M
---38.25M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities 176.71%5.11M118.63%1.85M-9.92M
Revenue from customers -10.91%260.46K102.95%292.36K---9.92M
Other cash income from operating activities 211.98%4.85M--1.56M----
Cash paid -11.69%-28.14M-25.19M
Payments to suppliers for goods and services -11.69%-28.14M---25.19M----
Direct interest received -65.19%50.48K--145.04K----
Operating cash flow 0.97%-22.98M-133.99%-23.2M---9.92M
Investing cash flow
Cash flow from continuing investing activities 94.60%-1.53M-28.37M
Net PPE purchase and sale -----1,548.09%-45.31K---2.75K
Net intangibles purchas and sale ----94.76%-1.49M---28.34M
Interest received (cash flow from investment activities) ----------8.83K
Net other investing changes -----------40K
Cash from discontinued investing activities
Investing cash flow ----94.60%-1.53M---28.37M
Financing cash flow
Cash flow from continuing financing activities 224.12%29.88M-85.84%9.22M65.11M
Net issuance payments of debt --2.2M-------59K
Net common stock issuance 204.97%28.11M-85.86%9.22M--65.17M
Net other financing activities ---437K--------
Cash from discontinued financing activities
Financing cash flow 224.12%29.88M-85.84%9.22M--65.11M
Net cash flow
Beginning cash position -56.64%11.7M99,486.97%26.98M--27.09K
Current changes in cash 144.48%6.9M-157.84%-15.51M--26.82M
Effect of exchange rate changes -110.67%-25.04K84.22%234.65K--127.37K
End cash Position 58.77%18.58M-56.64%11.7M--26.98M
Free cash from 7.10%-22.98M35.35%-24.73M---38.25M
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data